http://server.ccl.net/cca/info/conferencelist/mess0033500.shtml |
CCL 23.06.22 Flare V7: What's new for ligand-based and structure-based drug designers | |
From: chemistry-request at ccl.net To: chemistry-request at ccl.net Date: Fri Jun 9 06:11:15 2023 Subject: 23.06.22 Flare V7: What's new for ligand-based and structure-based drug designers Flare V7: What's new for ligand-based and structure-based drug designers? Flare⢠V7 has arrived! During this webinar we will guide you through an overview of the new structure-based functionality (such as GCNCMC in dynamics/FEP; ensemble covalent docking) and ligand-based functionality (such as QSAR workflow enhancements and new QM features) in Flare. We will also show you some of new features of the interface which help you maintain high productivity while using the platform to design new molecules. Please come and join us to hear about these exciting new features. Date: Thursday 22nd June, 2023 Time: 2pm BST / 3pm CEST / 9am EDT Duration: 45 minutes Format: Webinar Register here: https://www.cresset-group.com/about/events/flare-v7-whats-new/NOTE THAT E-MAIL ADDRESSES HAVE BEEN MODIFIED!!! All @ signs were changed to ^-^ to fight spam. Before you send e-mail, you need to change ^-^ to @ For example: change joe^-^big123comp.com to joe@big123comp.com Please let colleagues know about conference listingts at Computational Chemistry List Conference Page at http://www.ccl.net/chemistry/a/conferences/. Please help: If you find this conference list useful but you noticed some conference missing, please consider including it here by using the Conference Submission Page. It is free but your support is welcome. You will help others!!! |
[ CCL Home Page ]
[ Conferences ]
[ Jobs ]
[ Resumes ]
[ Raw Version of this page ]
Modified: Fri Jun 9 10:11:15 2023 GMT |
Page accessed 799 times since Fri Jun 9 10:11:16 2023 GMT |
Please help maintain CCL: If you found that your conference is listed here, please consider supporting CCL as a Supporting Member or use other Paid Services of CCL to ensure the continuation of this useful service. We cannot do it without your help.